. Observations and suggestions on antidementia drug development. Alzheimer Dis Assoc Disord. 1996;10 Suppl 1:31-5. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Aducanumab, Solanezumab, Gantenerumab Data Lift Crenezumab, As Well